Development of a brain permeable microtubule-targeting agent to treat glioblastoma

  • Munoz, Lenka (Investigator 01)
  • Kassiou, Michael (Investigator 02)
  • Johns, Terrance (Investigator 03)

Project Details

StatusFinished
Effective start/end date1/01/19 → 31/12/20

Funding

  • NHMRC National Health and Medical Research Council : A$115,000.00

  • Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

    Joun, G. L., Kempe, E. G., Chen, B., Sterling, J. R., Abbassi, R. H., Friess, D., Singleton, M., Choudhury, C., Marian, O. C., du Preez, W. D., Recasens, A., Clark, T., Du, T. Y., Low, J. K. K., Kim, H., Yang, P., Khor, J., Hoque, M., Indurthi, D. C. & Kuchibhotla, M. & 17 others, Palanisamy, R., Jorgensen, W. T., Montgomery, A. P., Baker, J. R., Higginbottom, S. L., Tomaskovic-Crook, E., Crook, J. M., Loo, L., Day, B. W., Neely, G. G., Guccione, E., Johns, T. G., Kassiou, M., Feng, Y., Harris, L., Don, A. S. & Munoz, L., 2025, In: Nature Communications. 16, 30 p., 10905.

    Research output: Contribution to journal › Article › peer-review

    Open Access